All‐trans retinoic acid (ATRA) in non‐promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low‐dose Ara‐C in three elderly patients with NPM1‐mutated AML unfit for intensive chemotherapy and review of the literature

Based upon the clinical behavior of three patients, we suggest that the combination of low‐dose Ara‐C and all‐trans retinoic acid may potentially be effective in some elderly patients, unfit for intensive chemotherapy, affected with NPM1‐mutated acute myeloid leukemia without FLT3 mutations, warrant...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Clin Case Rep
Auteurs principaux: Forghieri, Fabio, Bigliardi, Sara, Quadrelli, Chiara, Morselli, Monica, Potenza, Leonardo, Paolini, Ambra, Colaci, Elisabetta, Barozzi, Patrizia, Zucchini, Patrizia, Riva, Giovanni, Vallerini, Daniela, Lagreca, Ivana, Marasca, Roberto, Narni, Franco, Venditti, Adriano, Martelli, Maria Paola, Falini, Brunangelo, Lo Coco, Francesco, Amadori, Sergio, Luppi, Mario
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2016
Sujets:
Case Reports
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5134148/
https://ncbi.nlm.nih.gov/pubmed/27980750
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.723
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires